Previous 10 | Next 10 |
GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024 TriLink BioTechnologies (TriLink ® ), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, ha...
2023-05-16 09:51:06 ET Maravai Lifesciences ( NASDAQ: MRVI ) rose 5.5% on a report that the vaccine reagent vendor has attracted private equity interest. Private equity firm Thomas H. Lee Partners approached Maravai ( MRVI ) with a non-binding offer, according to a R...
2023-05-15 15:05:44 ET Summary Today, we take our first look at Maravai LifeSciences Holdings, Inc which was the subject of new takeover rumors last week. Both business segments of this nucleic acid production and biologics safety testing have seen sales fall drastically thanks to...
2023-05-12 15:00:44 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
2023-05-10 14:08:50 ET Maravai LifeSciences ( NASDAQ: MRVI ) briefly spiked up 9.5% and is now up 1% at least partly amid a report about renewed takeover speculation. There's some speculation that Maravai ( MRVI ) has drawn takeover interest, according to a B...
SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its newest cap analog, CleanCap® M6 . The latest CleanCap analog is expected to...
2023-05-09 01:00:26 ET Image source: The Motley Fool. Maravai LifeSciences (NASDAQ: MRVI) Q1 2023 Earnings Call May 08, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences (MRVI) Q1 2023 Earnings Ca...
2023-05-08 19:52:07 ET Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chairman of the Board and Interim CEO Kevin Herde - Chief Financial Of...
2023-05-08 16:17:27 ET Maravai LifeSciences Holdings press release ( NASDAQ: MRVI ): Q1 Non-GAAP EPS of $0.03 misses by $0.01 . Revenue of $79M (-67.7% Y/Y) misses by $0.72M . Updated Financial Guidance for 2023 Our financial guidance for the full year 20...
SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2023, together w...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...
2024-05-29 15:15:03 ET RBC Capital analyst issues OUTPERFORM recommendation for MRVI on May 29, 2024 01:35PM ET. The previous analyst recommendation was Outperform. MRVI was trading at $8.87 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...